Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the amount of caspofungin found in the blood of neonate
and infants <3 months of age following treatment with caspofungin at 25 mg/m2. Another
purpose is to test the safety of caspofungin in treating neonates and infants with Candida
infections (a certain type of fungal infection).